GABA (gamma-Aminobutyric acid) Market Growth (143.6 million by 2033 at 5.0% CAGR)

Introduction

The global GABA (gamma-aminobutyric acid) market is anticipated to grow significantly, with market size expected to reach USD 143.6 million by 2033, up from USD 88.1 million in 2023, at a CAGR of 5.0% during the forecast period from 2023 to 2033. Key growth factors include the rising demand for functional foods and beverages that incorporate GABA for its health benefits, particularly in stress and anxiety management. The increasing consumer awareness about mental health and the preference for natural remedies drive this demand.

However, challenges such as regulatory ambiguity, variability in product quality, and misleading claims about efficacy pose significant hurdles. Recent developments highlight the expansion of GABA into diverse product offerings, including energy drinks, teas, and snacks, catering to the growing health-conscious consumer base. The North American market, particularly, leads in GABA adoption, driven by technological advancements and high demand for stress management solutions in various industries.

Zhejiang YiWan Biolabs Co., Ltd. is a notable player in the GABA (gamma-aminobutyric acid) sector, focusing on producing high-quality GABA products for various applications, including dietary supplements and functional foods. The company is known for its advanced fermentation technologies and commitment to product purity and efficacy. Their research and development efforts aim to enhance GABA production efficiency and expand its applications in health and wellness.

Pharma Foods International Co., Ltd. is a key contributor to the GABA sector, specializing in the development and supply of GABA-based supplements and functional food ingredients. The company leverages its expertise in biochemistry to produce GABA through fermentation processes, ensuring high quality and bioavailability. Pharma Foods International focuses on innovation and quality control to meet growing consumer demand for GABA products that support relaxation and overall well-being.

Key Takeaways

• Market Growth: The GABA market is projected to reach USD 143.6 million by 2033, with a CAGR of 5.0% from 2023 to 2033.
• Segment Dominance: Chemical Synthesis holds over 66.1% of the market share in 2024.
• Top Application: Pharmaceuticals lead with over 38.2% market share in 2024.
• Preferred Sales Channel: Indirect Sales capture more than 68.3% of the market in 2024.
• Regional Leadership: North America leads the GABA market, capturing a 46.4% share in 2024.

Statistics

• As a general guideline, it is recommended to take no more than 1000 mg within 4 hours and no more than 3000 mg within 24 hours.
• The study was conducted on 89 patients with breast cancer in stage I-II. GABA level was assessed using the spectrofluorometric method in tumor homogenates. Immunoexpression of E-cadherin was evaluated histologically on paraffin-fixed specimens. Overall and disease-free survival was assessed for a 15-year interval period.
• Median overall survival was significantly longer (127.2 months) in patients with a high level of GABA (>89.3 μg/1), compared with a group with a low level of the amino acid (106.4 months). Disease-free survival was insignificantly different – 99 and 109 months, respectively.
• A significantly longer overall survival (131.2 months) was seen among patients with a high level of GABA and positive E-cadherin immunoexpression, compared with a group characterized by a low level of GABA and lack of E-cadherin immunoreactivity (98.1 months).
• The oral administration of GABA of 10 mg daily for 12 weeks was effective for hypertensive patients.
• The daily oral administration of rice germ containing 26.4 mg GABA was effective in treating neurological disorders.
• Organisms, including pseudomonads as well as higher organisms also showed the highest activity of GABA transaminase approximately at pH 8.5.
• DSM19463 synthesized the highest amount of GABA (59 µM/h) at temperatures between 30°C and 35°C.
• NFRI 7415 produced the highest GABA (302 mM) at 37°C, however drastically decreased the GABA production and cell growth at 43°C (43). Generally, fermenting temperatures ranging from 25°C to 40°C result in a high GABA yield within the temperatures.
• The time factor plays an important role in the fermentation and the production of GABA as temperature and pH do. Lb. plantarum DSM19463 and Lb. paracasei NFRI 7415 required 72 h and 144 h of fermentation to reach the highest production of GABA at 4.83 mM and 60 mM, respectively.
• The GABA production at 72 h reached 6272, 6570, and 7333 mg/l when PLP was added at 0, 24, and 48 h, respectively.
• A higher amount of GABA was produced by the addition of PLP at 48 h than at 0 and 24 h suggesting that PLP could easily lose the role as a coenzyme due to the denaturalization in the culture broth during the fermentation, however, the addition of PLP at 48 h could partly recover GAD activity.
• N-acetyl D-glucosamine and gluconate as carbon source, 1.25% glucose was the best carbon source for high production of GABA.
• The addition of each 2.5% yeast extract, soya peptone, and beef extract as a nitrogen source produced approximately 200 mM GABA.
• In the glucose-yeast peptone medium, 7% MSG as glucose concentration with 10 mM ammonium sulfate was the best combination for GABA production.

Don’t Miss Out: Get Your Hands on Our PDF Sample Report to Uncover the Market @ https://market.us/report/gaba-gamma-aminobutyric-acid-market/#requestSample

Emerging Trends

• Growing Health and Wellness Market: There is an increasing demand for GABA supplements in the health and wellness industry due to its benefits in stress reduction, improved sleep quality, and anxiety management. This trend is driven by rising consumer awareness about mental health and holistic approaches.
• Advancements in Production Technology: New fermentation and biotechnological methods are enhancing the efficiency and purity of GABA production. Companies are investing in these technologies to meet the growing demand and ensure high-quality, cost-effective GABA products.
• Expansion into Functional Foods: GABA is increasingly being incorporated into functional foods and beverages. This trend reflects a broader movement towards integrating beneficial compounds into everyday dietary products to enhance overall health.
• Rising Research and Development: There is a surge in research exploring GABA’s potential therapeutic applications beyond its traditional uses. Studies are focusing on its effects on neurological conditions, including its role in cognitive function and neuroprotection.
• Regulatory Changes: As GABA’s popularity grows, regulatory bodies are developing new guidelines to ensure the safety and efficacy of GABA-containing products. Companies need to stay updated with these regulations to ensure compliance and market access.
• Personalized Nutrition: The trend toward personalized nutrition is driving the development of tailored GABA supplements. Companies are offering products customized to individual health needs and genetic profiles, enhancing the effectiveness of GABA supplementation.

Use Cases

• Stress Reduction: GABA is widely used in supplements to help reduce stress and anxiety. Studies show that GABA supplementation can lower cortisol levels, which are associated with stress. In clinical trials, daily doses of 100 to 300 mg of GABA have demonstrated significant reductions in anxiety and improvements in relaxation.
• Improving Sleep Quality: GABA is often used to improve sleep quality. Research indicates that GABA supplements can help decrease the time it takes to fall asleep and increase total sleep time. For instance, a study found that 100 mg of GABA taken before bedtime led to improved sleep onset and duration.
• Support for Cognitive Function: There is growing interest in GABA’s role in enhancing cognitive function. Some studies suggest that GABA may improve attention and memory. For example, doses ranging from 100 to 200 mg have been explored for their potential cognitive benefits in research settings.
• Management of Hyperactivity and ADHD: GABA is used to help manage symptoms of hyperactivity and ADHD. It is thought to regulate neurotransmitter activity, which may help in reducing symptoms such as impulsivity and hyperactivity. Clinical usage varies, but GABA supplements are typically used in conjunction with other therapies.
• Muscle Relaxation and Recovery: GABA is used by athletes and fitness enthusiasts for muscle relaxation and recovery. It is believed to help reduce muscle tension and promote relaxation post-exercise. Supplementation of around 200 mg per day is commonly used for these purposes.
• Support for Neurodegenerative Diseases: Emerging research is investigating GABA’s potential in supporting brain health and managing neurodegenerative conditions. Preliminary studies suggest that GABA might play a role in protecting against conditions like Alzheimer’s disease, though more research is needed.

Key Players

Zhejiang YiWan Biolabs Co., Ltd. is a notable player in the GABA (gamma-Aminobutyric acid) sector, focusing on producing high-quality GABA products for various applications, including dietary supplements and functional foods. The company is known for its advanced fermentation technologies and commitment to product purity and efficacy. Their research and development efforts aim to enhance GABA production efficiency and expand its applications in health and wellness.

Pharma Foods International Co., Ltd. is a key contributor to the GABA sector, specializing in the development and supply of GABA-based supplements and functional food ingredients. The company leverages its expertise in biochemistry to produce GABA through fermentation processes, ensuring high quality and bioavailability. Pharma Foods International focuses on innovation and quality control to meet growing consumer demand for GABA products that support relaxation and overall well-being.

Guangdong Luckerkong Biotech Co., Ltd. is a key player in the GABA (gamma-Aminobutyric acid) sector, focusing on the production and supply of high-quality GABA. The company utilizes advanced fermentation technology to enhance GABA production, catering to various industries including food, pharmaceuticals, and health supplements. By leveraging cutting-edge biotechnological methods, Guangdong Luckerkong Biotech ensures that its GABA products meet stringent quality standards and contribute to the growing demand for functional ingredients.

Tocris Bioscience is notable in the GABA sector for providing a range of GABA-related research products. Specializing in scientific research and development, Tocris offers high-purity GABA and related compounds for academic and clinical research. Their products support studies on neurotransmission and potential therapeutic applications of GABA. Tocris’s commitment to quality and innovation makes it a valuable resource for researchers exploring the role of GABA in neurological studies.

Tianjin Shijitianlong Biotech Co., Ltd. is a notable player in the GABA (gamma-Aminobutyric acid) sector, focusing on the production of high-quality GABA products. The company emphasizes innovation in its manufacturing processes, aiming to enhance the purity and efficacy of its GABA offerings. Their products cater to various applications, including dietary supplements and pharmaceuticals, which benefit from GABA’s calming and neurotransmitter-supporting properties.

Taizhou Xinyou Pharmaceutical & Chemical Co., Ltd., Inc. is engaged in the GABA (gamma-Aminobutyric acid) market with a focus on producing and supplying high-grade GABA for use in dietary supplements and pharmaceutical applications. The company is known for its commitment to quality and its efforts to advance GABA production technology. Xinyou’s products are used to support relaxation and mental well-being, reflecting the growing demand for GABA in health-related products.

Wuhan Yuancheng Gongchuang Technology Co., Ltd, LLC is a prominent player in the GABA (gamma-Aminobutyric acid) sector, focusing on the production and supply of high-quality GABA for various applications, including dietary supplements and pharmaceuticals. The company is noted for its advanced production technologies and commitment to quality control, positioning itself as a reliable source in the global GABA market.

Ningxiang Jiayuan Biology Technology Co., Ltd. specializes in the development and manufacturing of GABA (gamma-Aminobutyric acid) products, catering to the dietary supplement and functional food industries. The company leverages modern biotechnological methods to ensure the purity and efficacy of its GABA offerings. Their innovative approach and high-quality standards contribute to their strong market presence.

Richen Nutritional Technology is actively enhancing the GABA sector by focusing on innovative production techniques and improving the bioavailability of GABA. Their advancements in nutritional technology aim to increase the efficacy of GABA supplements, targeting better health outcomes such as stress reduction and sleep improvement. This approach aligns with the growing consumer demand for functional foods and dietary supplements that support mental wellness.

Conclusion

In conclusion, the GABA (gamma-Aminobutyric acid) market is poised for steady growth due to increasing consumer interest in natural solutions for stress relief, improved sleep, and overall mental wellness. Advancements in production technologies and a growing emphasis on high-quality, bioavailable GABA supplements are driving market expansion. Companies like Richen Nutritional Technology and Ningxiang Jiayuan Biology Technology are contributing to this growth by focusing on innovation and quality. As awareness of GABA’s benefits continues to rise, the market is expected to expand further, offering opportunities for both established players and new entrants.

Sources:

• https://www.made-in-china.com/productdirectory.do?word=GABA+%28gamma-Aminobutyric+acid%29+&file=&searchType=0&subaction=hunt&style=b&mode=and&code=0&comProvince=nolimit&order=0&isOpenCorrection=1&org=top
• https://www.pharmafoods.co.jp/en/products/pharmagaba
• https://www.sciencedirect.com/topics/medicine-and-dentistry/gamma-aminobutyric-acid
• https://pubmed.ncbi.nlm.nih.gov/28954486/
• https://www.scielo.br/j/bjm/a/GppQ3My7zBYYbtkLtk8tjLG/
• https://www.made-in-china.com/productdirectory.do?word=GABA+%28gamma-Aminobutyric+acid%29+&file=&searchType=0&subaction=hunt&style=b&mode=and&code=0&comProvince=nolimit&order=0&isOpenCorrection=1&org=top
• https://www.pharmafoods.co.jp/en/products/pharmagaba
• http://en.luckerkong.com/Products_Detail/27.html
• https://www.tocris.com/products/gaba_0344
• https://www.echemi.com/searchGoods.html?keywords=gamma%2520aminobutyric%2520acid
• http://www.chemical-manufactures.com/supplier/id-18900_supplier_detail1.html
• https://www.richen-nutritional.com/search.php?s=gamma+aminobutyric+acid+&cat=490